Z-2453-2015 Class II Terminated
FDA device recall Z-2453-2015 was initiated by Becton, Dickinson And Company, BD Biosciences on Jul 17, 2015 and is designated Class II. Reason for recall: Three lots of CD56 PE Cy 7, Catalog number 335809, contain a low amount of HLA-DR PE antibody which could result in an unexpected staining pattern. The recall status is terminated (terminated Mar 11, 2016). Affected quantity: 362 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 2, 2015
- Initiation Date
- Jul 17, 2015
- Termination Date
- Mar 11, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 362 units
Product description
BD CD56 PE Cy 7: NCAM16.2 ASR Analyte Specific Reagent, Catalog number 335809 Hematology: The CD 56 antigen promotes homophilic adhesion in neurons and may be involved in homophilic adhesion of NK cells.
Reason for recall
Three lots of CD56 PE Cy 7, Catalog number 335809, contain a low amount of HLA-DR PE antibody which could result in an unexpected staining pattern.
Distribution pattern
US Distribution and Internationally to Taiwan.
Code information
Catalog number 335809; Lot numbers 4300708, 4304864, 5013643; all with expiry dates of 31 OCT 2015
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2453-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026